In the “any tumor vs. control” analysis (Figure 8b), apoptosis emerged as the best-performing biomarker (AUC = 0.895), followed by IL-6 (AUC = 0.832) and CA125 (AUC = 0.812), all of which showing excellent sensitivity and specificity rates. Here, MUC16 is linked to neoplasm.